Benzinga
28 Oct 2025, 18:45 UTC · 45w ago
Verdict
Headline leans bullish. We score LH +0.40 across five claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.40moderately bullish
What the story claims
5 claims · scored −1 bearish … +1 bullish
Labcorp lowered its fiscal year 2025 total sales guidance to $13.97 billion-$14.05 billion and sales growth to 7.4%-8%, down from prior guidance of $14.08 billion-$14.23 billion and 7.5%-8.6%.
So whatLowering top-line guidance signals a deceleration in revenue growth, which typically causes analysts and investors to re-rate the stock lower.
More negative than 95% of claims this week
Labcorp lowered its 2025 Biopharma Laboratory Services sales growth guidance to 5.7%-7.1% from the previous 6.1%-7.5%.
Continue reading
5 related stories
More positive than 66% of ticker scores this week
Scored by the NIS engine · methodology.
More negative than 86% of claims this week
William Blair reiterated an Outperform rating, citing steady organic growth, healthy utilization, stable pricing, and a solid M&A pipeline, while noting clarity on 2026 earnings is key for near-term share gains.
More positive than 66% of claims this week
Labcorp slightly raised the bottom end of its fiscal year 2025 adjusted earnings guidance from $16.05 to $16.15, keeping the top end at $16.50.
So whatA modest tightening and raising of the EPS floor signals bottom-line resilience and slightly offsets the negative impact of the lowered sales guidance.
More positive than 55% of claims this week
Labcorp reported Q3 2025 adjusted EPS of $4.18 and sales of $3.56 billion, meeting consensus expectations exactly.
More positive than 47% of claims this week
Which stocks this story touches
More positive than 66% of ticker scores this week
The company beat earnings and sales expectations and received a reiterated Outperform rating, though it slightly lowered full-year sales guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
6h ago
+14.4%
Price agrees with the score
$315.31 vs $275.66 close before publication (Oct 27) · not market-adjusted
LH chart →
